in St Petersburg, FL
KYBELLA® is the first and only FDA-approved injectable treatment to improve the appearance of moderate to severe fat beneath the chin* by physically destroying fat cells. KYBELLA is a good alternative for patients who are not interested surgery or laser procedures but are bothered by submental fullness under the chin.
How does KYBELLA® work?
When injected into the fat beneath your chin, KYBELLA® destroys fat cells. Once destroyed, those cells cannot store or accumulate fat.
The active ingredient in KYBELLA® is deoxycholic acid, a naturally occurring molecule in the body that aids in the breakdown and absorption of dietary fat. Fat cleared from the treatment area is processed through your body’s natural metabolism.
How many treatment sessions will I need?
Dr. Coundouriotis would determine how many treatment sessions you need based on the amount and distribution of your submental fat and your personal treatment goals. KYBELLA® is injected during an in-office visit with injection process taking about 20 minutes.
Up to 6 treatments may be administered, but most patients are complete after 2 to 3 treatments. Treatments are usually spaced 1 month to 6 weeks apart.
What can I expect after my treatment session?
For most patients, downtime occurred most commonly after the first treatment session. Normal daily activities can be resumed, but you are likely to have swelling for the first 24 to 48 hours.
Prior to your treatment session, Dr. Coundouriotis may recommend that you take an over-the-counter pain reliever before your appointment. After the treatment, we recommend applying ice or cold packs to the treatment area to make you more comfortable.
Will there be side effects?
KYBELLA® can cause several side effects, the most common include:
• Swelling • Numbness
• Bruising • Redness
• Pain • Areas of hardness
There may also be more serious side effects, including nerve injury in the jaw that can cause an uneven smile or facial muscle weakness (experienced by 4 out of 100 people in clinical studies) and trouble swallowing (experienced by 2 out of 100 people in clinical studies).